UY29843A1 - Inhibidores de la enzima integrasa de vih - Google Patents

Inhibidores de la enzima integrasa de vih

Info

Publication number
UY29843A1
UY29843A1 UY29843A UY29843A UY29843A1 UY 29843 A1 UY29843 A1 UY 29843A1 UY 29843 A UY29843 A UY 29843A UY 29843 A UY29843 A UY 29843A UY 29843 A1 UY29843 A1 UY 29843A1
Authority
UY
Uruguay
Prior art keywords
inhibitors
integrated hiv
hiv enzyme
enzyme
integrated
Prior art date
Application number
UY29843A
Other languages
English (en)
Inventor
Huichun Zhu
Steven Paul Tanis
Red William Johnson
Klaus Ruprecht Dress
Michael Bruno Plewe
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37684843&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY29843(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY29843A1 publication Critical patent/UY29843A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a compuestos de la fórmula (I), y sus sales y solvatos farmacéuticamente aceptables, su síntesis, y su uso como moduladores o inhibidores de la enzima integrasa del virus de la inmunodeficiencia humano ("VIH").
UY29843A 2005-10-07 2006-10-06 Inhibidores de la enzima integrasa de vih UY29843A1 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US72448405P 2005-10-07 2005-10-07
US73070105P 2005-10-26 2005-10-26
US76160506P 2006-01-24 2006-01-24
US82395406P 2006-08-30 2006-08-30
US82637906P 2006-09-20 2006-09-20

Publications (1)

Publication Number Publication Date
UY29843A1 true UY29843A1 (es) 2007-05-31

Family

ID=37684843

Family Applications (1)

Application Number Title Priority Date Filing Date
UY29843A UY29843A1 (es) 2005-10-07 2006-10-06 Inhibidores de la enzima integrasa de vih

Country Status (21)

Country Link
US (1) US20070099915A1 (es)
EP (1) EP1934220A1 (es)
JP (1) JP2009511463A (es)
KR (1) KR20080042171A (es)
AP (1) AP2008004400A0 (es)
AR (1) AR061398A1 (es)
AU (1) AU2006300926A1 (es)
BR (1) BRPI0616657A2 (es)
CA (1) CA2623506A1 (es)
CR (1) CR9859A (es)
EA (1) EA200800758A1 (es)
IL (1) IL189939A0 (es)
MA (1) MA29855B1 (es)
NL (1) NL2000255A1 (es)
NO (1) NO20081230L (es)
PE (1) PE20070494A1 (es)
RS (1) RS20080141A (es)
SV (1) SV2009002864A (es)
TW (1) TW200800219A (es)
UY (1) UY29843A1 (es)
WO (1) WO2007042883A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2292123T3 (es) * 2004-04-26 2008-03-01 Pfizer Inc. Inhibidores de la enzima integrasa de vih.
CA2708281A1 (en) 2007-12-11 2009-08-27 Viamet Pharmaceuticals, Inc. Metalloenzyme inhibitors using metal binding moieties in combination with targeting moieties
CN102532021B (zh) * 2012-01-31 2013-10-16 天津大学 2-烷氧基-3,4-二取代异喹啉-1(2h)-酮类衍生物的制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) * 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
AU2409992A (en) * 1991-08-08 1993-03-02 Tsumura & Co. Carcinostatic compound and production thereof
AU7225494A (en) * 1993-07-19 1995-02-20 Zelin Li Qinghaosu derivatives against aids
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
WO2001027309A1 (en) * 1999-10-13 2001-04-19 Merck & Co., Inc. Hiv integrase inhibitors
BR0111570A (pt) * 2000-06-16 2003-09-09 Bristol Myers Squibb Co Inibidores de integrase de hiv
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
MXPA05007563A (es) * 2003-01-27 2005-09-21 Pfizer Inhibidores de la integrasa del vih, composiciones farmaceuticas y metodos para su uso.
ES2292123T3 (es) * 2004-04-26 2008-03-01 Pfizer Inc. Inhibidores de la enzima integrasa de vih.
JP2008512442A (ja) * 2004-09-07 2008-04-24 ファイザー・インク Ｈｉｖインテグラーゼ酵素の阻害剤

Also Published As

Publication number Publication date
AR061398A1 (es) 2008-08-27
EP1934220A1 (en) 2008-06-25
TW200800219A (en) 2008-01-01
PE20070494A1 (es) 2007-06-13
RS20080141A (en) 2009-07-15
CR9859A (es) 2008-06-20
KR20080042171A (ko) 2008-05-14
EA200800758A1 (ru) 2008-08-29
AU2006300926A1 (en) 2007-04-19
US20070099915A1 (en) 2007-05-03
CA2623506A1 (en) 2007-04-19
SV2009002864A (es) 2009-02-19
NL2000255A1 (nl) 2007-04-11
WO2007042883A1 (en) 2007-04-19
MA29855B1 (fr) 2008-10-03
IL189939A0 (en) 2008-08-07
JP2009511463A (ja) 2009-03-19
NO20081230L (no) 2008-04-08
AP2008004400A0 (en) 2008-04-30
BRPI0616657A2 (pt) 2011-06-28

Similar Documents

Publication Publication Date Title
BRPI0510319A (pt) inibidores da enzima integrase de hiv
UY29927A1 (es) Derivados sustituidos de la 5-fenil-2-tioxo-imidazolin-4-ona y de la 5-fenil-2-amino-imidazolidin-4-ona y sus sales, composiciones y aplicaciones
UY30426A1 (es) Derivados sustituidos del 3-(4-metoxi-fenil)-3h-isoindol-1-ilamina trifluoroacetado, sus sales o solvatos farmaceuticamente aceptables, formulaciones farmacéuticas y aplicaciones.
UY30274A1 (es) Derivados sustituidos de la n-(4-metil-1,3-tiazol-2-il)guanidina, formulaciones farmacéuticas conteniéndolo y aplicaciones
UY27350A1 (es) Azaindoles
BRPI0819328A8 (pt) Compostos inibidores de replicação de vírus da imunodeficiência humana, composição farmacêutica e uso dos ditos compostos
GT200600134A (es) Compuestos novedosos de derivados de aminosulfonilo
TN2010000212A1 (en) Inhibitors of human immunodeficiency virus replication
CR10149A (es) Agentes citotóxicos que comprenden nuevos derivados de tomaimicina y su uso terapéutico
CL2011001658A1 (es) Compuestos derivados de sulfonamidas, moduladores de los canales de sodio; composición farmacéutica que los comprende; y su uso en el tratamiento del dolor.
UY30498A1 (es) Nueva clase de compuestos de benzimidazolilo, sus sales, composiciones farmacéuticas conteniéndolos y aplicaciones
NI200900040A (es) Derivados de quinazolinona 5-substituidos como agentes antitumorales.
CO6741203A2 (es) Derivados de biciclo[3,2,1]octilamida y sus usos
ECSP099476A (es) Compuestos carboxamida y su uso como inhibidores de calpaína
ECSP088593A (es) 5-(arilsulfonil)-pirazolopiperidinas
MA31889B1 (fr) N-phenyl -bipyrrolidine-urees substituees et utilisation therapeutique de celles-ci
ES2422275T3 (es) Derivado del oxindol sustituido y su uso como un modulador del receptor de la vasopresina
ECSP088677A (es) Piperazinas y piperidinas como potenciadores 157 del mglur5
ECSP089019A (es) Inhibidores de sulfonamida tricíclicos, fusionados del gama secretasa
CR9722A (es) Derivados de benzilpiperazina y su uso medico
PA8568101A1 (es) Indolil-urea derivados de tienopiridinas utiles como agentes antiangiogenicos, y procedimientos para su uso
UY29999A1 (es) "n-pirazinil-fenilsulfonamidas, procedimientos y compuestos intemedios utilizados en su preparacion, composiciones farmaceuticas que las contienen y aplicaciones"
UY29394A1 (es) Derivados sustituidos de n-(5-(2-propilamino.1.hidroxietil)-2-hdroxifenil) metano sulfonamida, composiciones farmacéuticas que lo contienen y aplicaciónes.
GT201000298A (es) 2,6-diamino-pirimidin-z-il-carboxamidas como inhibidores de syk o jak quinasas
MY157425A (en) Substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20160930